Early Recognition and Optimal Treatment of Delirium in Patients With Advanced Cancer

Trial Profile

Early Recognition and Optimal Treatment of Delirium in Patients With Advanced Cancer

Completed
Phase of Trial: Phase III

Latest Information Update: 10 Apr 2017

At a glance

  • Drugs Olanzapine (Primary) ; Haloperidol; Haloperidol
  • Indications Cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Apr 2017 Status changed from recruiting to completed.
    • 08 Dec 2015 Planned End Date changed from 1 Aug 2015 to 1 Aug 2016, as reported by ClinicalTrials.gov.
    • 08 Dec 2015 Planned primary completion date changed from 1 Aug 2015 to 1 Aug 2016, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top